Rticc
Seleccione idioma:  
Buscar:
RTICC 2013
Programas RTICC
Agenda
Seguimiento cientifico
 
INTRODUCTION

At the beginning of the 21st century, lung cancer continues to be the world's leading cause of preventable death. Lung cancer was a rare disease at the start of the past century, but the generalization of smoking made lung cancer one of the largest epidemics of the 20th century. By the early 1950s, case-control studies showed that cigarette smoking was causally associated with an increased risk of lung cancer, and this association was later corroborated by cohort studies. By 1964, the evidence was sufficient to support a conclusion by the US Surgeon General that cigarette smoking caused lung cancer. + more...

BACKGROUND AND OBJECTIVES

FUNCTIONAL STRUCTURE OF THE PROGRAMME

SYNERGIES

CRITICAL MASS

MANAGEMENT STRUCTURE AND COORDINATION

ADDED VALUE OF THE RESEARCH GROUPS FROM THE COOPERATIVE STRUCTURE

INTERNATIONAL NETWORKING

IMPACT AND TRANSFER

SCHEME OF EVALUATION OF THE PROGRAMME

Introducción
Coordinador
Grupos
Work Packages
Publicaciones
Proyectos
Ensayos clínicos
Otros resultados
Agenda
Enlaces
Intranet
Noticias
21/10/2016 | Reuniones RTICC
22/06/2016 | Otras reuniones
27/05/2016 | Otras reuniones
26/05/2016 | Otras reuniones
21/10/2015 | Congresos
20/10/2015 | Reuniones RTICC
Publicaciones
RD12/0036/0028
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer.
Paz-Ares L, Bálint B, de Boer RH, van Meerbeeck JP, Wierzbicki R, De Souza P, Galimi F, Haddad V, Sabin T, Hei YJ, Pan Y, Cottrell S, Hsu CP, RamLau R
J Thorac Oncol  2013.  3.  329-37.  PMID: 23370314. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage.
Pastor MD, Nogal A, Molina-Pinelo S, Meléndez R, Romero-Romero B, Mediano MD, López-Campos JL, García-Carbonero R, Sanchez-Gastaldo A, Carnero A, Paz-Ares L
Int J Mol Sci  2013.  2.  3440-55.  PMID: 23389041. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
The PARAMOUNT study and the re-challenge chemotherapy issue in advanced non-small cell lung cancer.
Gridelli C, Paz-Ares L
Eur J Cancer  2013.  9.  2271-2.  PMID: 23541565. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
Proteomic biomarkers in lung cancer.
Pastor MD, Nogal A, Molina-Pinelo S, Carnero A, Paz-Ares L
Clin Transl Oncol  2013.  9.  671-82.  PMID: 23606351. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
Identification of proteomic signatures associated with lung cancer and COPD.
Pastor MD, Nogal A, Molina-Pinelo S, Meléndez R, Salinas A, González De la Peña M, Martín-Juan J, Corral J, García-Carbonero R, Carnero A, Paz-Ares L
J Proteomics  2013.  227-37.  PMID: 23665002. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
Lung cancer in 2013: state of the art therapy for metastatic disease.
Shepherd FA, Bunn PA, Paz-Ares L
Am Soc Clin Oncol Educ Book  2013.  339-46.  PMID: 23714542. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.
Estevez-Garcia P, Lopez-Calderero I, Molina-Pinelo S, Muñoz-Galvan S, Salinas A, Gomez-Izquierdo L, Lucena-Cacace A, Felipe-Abrio B, Paz-Ares L, Garcia-Carbonero R, Carnero A
Clin Cancer Res  2013.  14.  3925-35.  PMID: 23729363. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
Inhibition of HSP90 molecular chaperones: moving into the clinic.
Garcia-Carbonero R, Carnero A, Paz-Ares L
Lancet Oncol  2013.  9.  e358-69.  PMID: 23896275. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
VeriStrat: a prognostic and/or predictive biomarker for advanced lung cancer patients?
Molina-Pinelo S, Pastor MD, Paz-Ares L
Expert Rev Respir Med  2014.  1.  1-4.  PMID: 24308656. 
Grupos colaboradores: RD12/0036/0028

RD12/0036/0028
Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.
Agulló-Ortuño MT, Díaz-García CV, Agudo-López A, Pérez C, Cortijo A, Paz-Ares L, López-Ríos F, Pozo F, de Castro J, Cortés-Funes H, López Martín JA
J Cancer Res Clin Oncol  2015.  1.  43-53.  PMID: 25081930. 
Grupos colaboradores: RD12/0036/0028

ISCII
ISCII
 
Ministerio de Economia y Competitividad
Descargar
Red Temática Investigación Cooperativa Sanitaria
Rticc 2012
Logotipos
 
ISCII
Red Temática Investigación Cooperativa en Cáncer (RTICC)
Centro de Investigación Cáncer - Campus Miguel de Unamuno - 37007 - Salamanca
(+34) 923294803 - sec.rticc[arroba]usal.es
|
|
|
|
 
Sobre la RTICC Programas RTICC Ofertas de empleo y Agenda Seguimiento científico
Red Temática de Investigación Cooperativa en Cáncer · © Copyright 2013 · sec.rticc[arrroba]usal.es · diseño web: detrazos
RSS